Corton Capital’s Astera Labs ALAB Stock Holding History

Corton Capital’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,258	Closed	-$299K	–	441
2024 Q4	$299K	Buy	+2,258	New	+$212K	0.17%	100

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Corton Capital's ALAB Position: Q1 2025 in Review

Corton Capital sold out of Astera Labs (ALAB) in Q1 2025, closing a stake of 2,258 shares — an estimated $299K sold.

Corton Capital first reported a position in ALAB in Q4 2024 and held it in 1 quarter. The position peaked at $299K in Q4 2024. 391 funds tracked by Wall St. Rank hold ALAB as of Q1 2025.

Corton Capital reported no remaining Astera Labs position as of Q1 2025 after selling out during the quarter.
Corton Capital sold 2,258 Astera Labs shares in Q1 2025, an estimated $299K.
Corton Capital first reported a position in Astera Labs in Q4 2024 and held it in 1 quarter.
Corton Capital's Astera Labs position peaked at $299K in Q4 2024.
391 funds tracked by Wall St. Rank held Astera Labs as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.